(S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol - CAS 116539-55-0
Catalog: |
BB003762 |
Product Name: |
(S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol |
CAS: |
116539-55-0 |
Synonyms: |
2-Thiophenemethanol, α-[2-(methylamino)ethyl]-, (αS)-; 2-Thiophenemethanol, α-[2-(methylamino)ethyl]-, (S)-; (1S)-(-)-3-(Methylamino)-1-(thien-2-yl)propan-1-ol; (1S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol; (S)-(-)-3-(N-Methylamino)-1-(2-thienyl)-1-propanol; (S)-(-)-3-Methylamino-1-(2-thienyl)propan-1-ol; (S)-3-Methylamino-1-(2-thienyl)-1-propanol; N-Methyl-(S)-(-)-3-Hydroxy-3-(2-thiophen)propylamine; (αS)-α-[2-(Methylamino)ethyl]-2-thiophenemethanol; Duloxetine EP Impurity B |
IUPAC Name: | (1S)-3-(methylamino)-1-thiophen-2-ylpropan-1-ol |
Description: | (S)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol is an impurity of Duloxetine, an antidepressant medication used to treat major depressive disorder. |
Molecular Weight: | 171.26 |
Molecular Formula: | C8H13NOS |
Canonical SMILES: | CNCCC(C1=CC=CS1)O |
InChI: | InChI=1S/C8H13NOS/c1-9-5-4-7(10)8-3-2-6-11-8/h2-3,6-7,9-10H,4-5H2,1H3/t7-/m0/s1 |
InChI Key: | YEJVVFOJMOHFRL-ZETCQYMHSA-N |
Boiling Point: | 294.3±35.0°C at 760 mmHg |
Melting Point: | 70.5-73.0°C |
Purity: | 98.0% |
Density: | 1.128±0.06 g/cm3 |
Solubility: | Soluble in Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
Appearance: | Off-white to Pink Solid |
Storage: | Store at -20°C |
MDL: | MFCD07357308 |
LogP: | 1.78190 |
Publication Number | Title | Priority Date |
CN-110229796-A | Ketoreductase mutant and its preparing the application in Duloxetine chirality alcohol intermediate and the like | 20190523 |
WO-2020089477-A1 | New alcoxyaminopyridine derivatives for treating pain and pain related conditions | 20181102 |
WO-2020089478-A1 | New tetrahydropyrimidodiazepin and tetrahydropyridodiazepin compounds for treating pain and pain related conditions | 20181102 |
TW-202031264-A | New alcoxyaminopyridine derivatives for treating pain and pain related conditions | 20181102 |
CN-113166147-A | Novel tetrahydropyrimidine diazepine and tetrahydropyridine diazepine compounds for the treatment of pain and pain-related disorders | 20181102 |
Complexity: | 110 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 171.07178521 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 171.07178521 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 60.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
-
[146651-71-0]
2-Methyl-2-propanyl [1,3-dihydroxy-2-(hydroxymethyl)-2-propanyl]carbamate
-
[1393527-23-5]
Phosphoric acid 6,6'-di(9-anthryl)-1,1'-spirobiindan-7,7'-diyl ester
-
[85531-02-8]
5-(Bromomethyl)undecane
-
[34374-88-4]
2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[133407-82-6]
MG-132
INDUSTRY LEADERS TRUST OUR PRODUCTS